246 related articles for article (PubMed ID: 17353439)
1. Amplified expression profiling of platelet transcriptome reveals changes in arginine metabolic pathways in patients with sickle cell disease.
Raghavachari N; Xu X; Harris A; Villagra J; Logun C; Barb J; Solomon MA; Suffredini AF; Danner RL; Kato G; Munson PJ; Morris SM; Gladwin MT
Circulation; 2007 Mar; 115(12):1551-62. PubMed ID: 17353439
[TBL] [Abstract][Full Text] [Related]
2. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease.
Morris CR; Kato GJ; Poljakovic M; Wang X; Blackwelder WC; Sachdev V; Hazen SL; Vichinsky EP; Morris SM; Gladwin MT
JAMA; 2005 Jul; 294(1):81-90. PubMed ID: 15998894
[TBL] [Abstract][Full Text] [Related]
3. Expression of regulatory platelet microRNAs in patients with sickle cell disease.
Jain S; Kapetanaki MG; Raghavachari N; Woodhouse K; Yu G; Barge S; Coronnello C; Benos PV; Kato GJ; Kaminski N; Gladwin MT
PLoS One; 2013; 8(4):e60932. PubMed ID: 23593351
[TBL] [Abstract][Full Text] [Related]
4. Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy.
Kato GJ; Gladwin MT
JAMA; 2008 Dec; 300(22):2638-46. PubMed ID: 19066384
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of vasculopathy in sickle cell disease and thalassemia.
Morris CR
Hematology Am Soc Hematol Educ Program; 2008; ():177-85. PubMed ID: 19074078
[TBL] [Abstract][Full Text] [Related]
6. RNA-seq transcriptional profiling of Leishmania amazonensis reveals an arginase-dependent gene expression regulation.
Aoki JI; Muxel SM; Zampieri RA; Laranjeira-Silva MF; Müller KE; Nerland AH; Floeter-Winter LM
PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006026. PubMed ID: 29077741
[TBL] [Abstract][Full Text] [Related]
7. Platelet activation and platelet-erythrocyte aggregates in patients with sickle cell anemia.
Wun T; Paglieroni T; Tablin F; Welborn J; Nelson K; Cheung A
J Lab Clin Med; 1997 May; 129(5):507-16. PubMed ID: 9142047
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a metabolic shift of arginine metabolism in sickle cell disease.
Schnog JJ; Jager EH; van der Dijs FP; Duits AJ; Moshage H; Muskiet FD; Muskiet FA
Ann Hematol; 2004 Jun; 83(6):371-5. PubMed ID: 15054669
[TBL] [Abstract][Full Text] [Related]
9. Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease.
Jison ML; Munson PJ; Barb JJ; Suffredini AF; Talwar S; Logun C; Raghavachari N; Beigel JH; Shelhamer JH; Danner RL; Gladwin MT
Blood; 2004 Jul; 104(1):270-80. PubMed ID: 15031206
[TBL] [Abstract][Full Text] [Related]
10. Coexpression network analysis of platelet genes in sickle cell disease.
Liu FF; Tu TT; Zhang HF; Hu F; Huang L; Deng LF; Guo M; Wei Q; Li K
Platelets; 2019; 30(8):1022-1029. PubMed ID: 30663491
[TBL] [Abstract][Full Text] [Related]
11. Arginine metabolism, pulmonary hypertension, and sickle cell disease.
Kielstein JT; Cooke JP
JAMA; 2005 Nov; 294(19):2433; author reply 2433-4. PubMed ID: 16287950
[No Abstract] [Full Text] [Related]
12. New strategies for the treatment of pulmonary hypertension in sickle cell disease : the rationale for arginine therapy.
Morris CR
Treat Respir Med; 2006; 5(1):31-45. PubMed ID: 16409014
[TBL] [Abstract][Full Text] [Related]
13. Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability.
Hsu LL; Champion HC; Campbell-Lee SA; Bivalacqua TJ; Manci EA; Diwan BA; Schimel DM; Cochard AE; Wang X; Schechter AN; Noguchi CT; Gladwin MT
Blood; 2007 Apr; 109(7):3088-98. PubMed ID: 17158223
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress, l-arginine-nitric oxide and arginase pathways in platelets from adolescents with anorexia nervosa.
Rodrigues Pereira N; Bandeira Moss M; Assumpção CR; Cardoso CB; Mann GE; Brunini TM; Mendes-Ribeiro AC
Blood Cells Mol Dis; 2010 Mar; 44(3):164-8. PubMed ID: 20071203
[TBL] [Abstract][Full Text] [Related]
15. Arginase levels and their association with Th17-related cytokines, soluble adhesion molecules (sICAM-1 and sVCAM-1) and hemolysis markers among steady-state sickle cell anemia patients.
Vilas-Boas W; Cerqueira BA; Zanette AM; Reis MG; Barral-Netto M; Goncalves MS
Ann Hematol; 2010 Sep; 89(9):877-82. PubMed ID: 20405289
[TBL] [Abstract][Full Text] [Related]
16. Arginine therapy: a new treatment for pulmonary hypertension in sickle cell disease?
Morris CR; Morris SM; Hagar W; Van Warmerdam J; Claster S; Kepka-Lenhart D; Machado L; Kuypers FA; Vichinsky EP
Am J Respir Crit Care Med; 2003 Jul; 168(1):63-9. PubMed ID: 12626350
[TBL] [Abstract][Full Text] [Related]
17. Association between arginase-containing platelet-derived microparticles and altered plasma arginine metabolism in polycystic ovary syndrome.
Kyselova A; Hinrichsmeyer H; Zukunft S; Mann AW; Dornauf I; Fleming I; Randriamboavonjy V
Metabolism; 2019 Jan; 90():16-19. PubMed ID: 30367832
[TBL] [Abstract][Full Text] [Related]
18. Platelet P-selectin expression in patients with sickle cell disease who undergo apheresis.
Boga C; Ozdogu H; Kozanoglu I; Sozer O; Sezgin N; Kizilkilic E; Bakar C
Ther Apher Dial; 2007 Aug; 11(4):255-61. PubMed ID: 17661830
[TBL] [Abstract][Full Text] [Related]
19. Platelet hyperaggregability in obesity: is there a role for nitric oxide impairment and oxidative stress?
Leite NR; Siqueira de Medeiros M; Mury WV; Matsuura C; Perszel MB; Noronha Filho G; Brunini TM; Mendes-Ribeiro AC
Clin Exp Pharmacol Physiol; 2016 Aug; 43(8):738-44. PubMed ID: 27145241
[TBL] [Abstract][Full Text] [Related]
20. Low plasma levels of L-arginine, impaired intraplatelet nitric oxide and platelet hyperaggregability: implications for cardiovascular disease in depressive patients.
Pinto VL; de Souza PF; Brunini TM; Oliveira MB; Moss MB; Siqueira MA; Ferraz MR; Mendes-Ribeiro AC
J Affect Disord; 2012 Oct; 140(2):187-92. PubMed ID: 22424639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
